Skip to content

Depression: all studies

Page 438 of 1,034: studies 4,371 to 4,380 of 10,336, newest first. Back to the depression overview

Research

650. Anxiolytic effects of serotoninergic psychedelics on patients with psychiatric disorders

The International Journal of Neuropsychopharmacology September 9, 2026 R Freire, C Chaves, M Cabo et al.

Abstract Background Anxiety disorders are among the most prevalent psychiatric disorders worldwide, causing significant impacts on physical and emotional health and substantial functional impairment. Not only individuals with anxiety disorders have severe and debilitating anxiety symptoms; patients with PTSD, OCD and mood disorders often present with anxiety. The term classic psychedelics...

477. Antidepressant action of short-acting psychedelics

The International Journal of Neuropsychopharmacology September 9, 2026 J Ramaekers

Abstract Background Short-acting psychedelics such as 5-MeO-DMT and DMT may induce rapid relief of depressive symptoms after brief but intense psychedelic experiences. Aims & Objectives This presentation examines their clinical pharmacology and therapeutic potential in depression. Method Review of clinical data. Results Both compounds primarily target serotonergic receptors, notably 5-HT1A and...

Ketamine-Assisted Intensive Short-Term Dynamic Psychotherapy

Psychoanalytic Inquiry September 8, 2026 Allen Kalpin

In recent years, researchers have demonstrated that the dissociative anesthetic ketamine provides therapeutic benefits for depression and other mental health problems, and when combined with psychotherapy, it is considered a type of psychedelic-assisted psychotherapy. In this article, I first review the main issues surrounding ketamine-assisted psychotherapy and then describe the psychodynamic...

The mindfulness-based social work and self-care programme: Initial roll out and expanded findings

The British Journal of Social Work September 8, 2026 Alan Maddock, Talal Sultan M. Althobity, Karen McGuigan

Abstract Stress and burnout can have serious negative effects on individual social workers and the organizations they work for. Preliminary evaluations of the Mindfulness-Based Social Work and Self-Care (MBSWSC) programme have found that it reduces stress, burnout, depression, and anxiety and improves the mental well-being of social workers. Building on this evidence, the programme is currently...

The Effectiveness of Mindfulness-Based Interventions in Enhancing Psychological Well-Being in Athletes: A Scoping Review of Randomised Controlled Trials

Healthcare September 8, 2026 Nafih Cherappurath, Halil İbrahim Ceylan, E. Anakha et al.

Background/Objectives: Mindfulness-based interventions (MBIs) have gained increasing attention in sport psychology due to their potential to enhance psychological well-being and performance-related outcomes among athletes. Despite various systematic reviews and meta-analyses examining mindfulness in athletic contexts, broader scoping evidence mapping randomised controlled trials (RCTs) of MBIs...

Chapter 2 – The Dark Day: On the Dark Night of the Soul. A Contemporary Interpretation of John of the Cross

Zenodo (CERN European Organization for Nuclear Research) September 7, 2026 Rebekka Waldesruh preprint

This chapter examines one of the central misunderstandings surrounding the phenomenon traditionally referred to as the “Dark Night of the Soul”: its frequent reduction to clinical depression. Building on the introductory chapter, the present section develops a differentiated comparison between depressive states and the transformative process described in mystical traditions, particularly in the...

Safety and Efficacy of Natural and Conventional Psychiatric Treatments: A Comparative Review of Mushroom-Derived Compounds and Medicinal Plants in the Management of Mental Disorders

Molecules September 7, 2026 Katarzyna Gawłowska, Katarzyna Kaja Nowakowska, Julia Wiktoria Makówka et al.

Standard pharmacotherapy for mental disorders, including depression and anxiety, is supported by extensive clinical validation and international treatment guidelines. However, it is frequently associated with limitations such as adverse side effects, low patient adherence, and the risk of relapse. Conventional approaches rely primarily on antidepressants, anxiolytics, mood stabilizers,...

The effect of ketamine on mitochondrial bioenergetics, viability, and function: A systematic review.

Journal of Psychopharmacology September 7, 2026 Sabrina Wong, Gia Han Le, Simryn Selby et al.

Extant literature indicates mitochondrial dysfunction may contribute to the pathophysiology of depressive disorders. Preclinical data indicate that anesthetic doses of ketamine are associated with deficits in mitochondrial viability and function. Ketamine and esketamine have demonstrated rapid antidepressant effects in persons with difficult-to-treat depressive disorders. Herein, we aim to...

Dispositional mindfulness and neuroticism are associated with age differences in emotional well-being in a U.S. adult lifespan sample

Scientific Reports September 5, 2026 Merrisa Lin, Nairán Ramírez‐Esparza, Natalie J. Shook

Despite experiencing more negative life events, older adults often report better emotional well-being than younger adults, a phenomenon known as the well-being paradox. Although socioemotional selectivity theory suggests that age-related shifts toward present-moment goals may contribute to this pattern, the psychological factors underlying these age differences remain unclear. In particular,...

Schizoidism and Syntony vis-à-vis Plessner, Autopoiesis, and 4E Cognition.

September 5, 2026 Maurício Viotti Daker

BACKGROUND: The schizoidism-syntony dyad offers a good start for a comprehensive view of psychopathology. Rooted in schizophrenia and manic-depressive illness in Kretschmer's characterology, these concepts gained prominence, under Bleuler and Minkowski, as expressions of personal relational patterns to the environment. SUMMARY: It seems insightful, therefore, to compare the concepts to the...